Roche Glycart AG
Company Overview
Previous Company Names
- GlycArt Biotechnology GmbH
- (GlycArt Biotechnology Ltd liab. Co)
- GlycArt Biotechnology AG
- (GlycArt Biotechnology Ltd.)
- (GlycArt Biotechnology Ltd)
Management
Michaela Stoltz
Weil am Rhein, DE
Joint signing authority (any two to sign)
Ronald Gacond-Weisser
Therwil
Limited joint signing authority (any two to sign)
Daniel Schillinger
Denzlingen, DE
Limited joint signing authority (any two to sign)
Priska Rüegg
Zürich
Limited joint signing authority (any two to sign)
Patricia Alioth
Reinach
Joint signing authority (any two to sign)
Corinne Frech
Pully
Limited joint signing authority (any two to sign)
Sabrina Milde
Wahlen
Limited joint signing authority (any two to sign)
Lioba Eschbach
Wehr, DE
Limited joint signing authority (any two to sign)
Michèle Rohrbach
Kaiseraugst
Limited joint signing authority (any two to sign)
Manuel von Allmen
Oberwil
Limited joint signing authority (any two to sign)
Ashley Lakner
Basel
Joint signing authority (any two to sign)
Christiane Neumann
Oberweningen
Limited joint signing authority (any two to sign)
Claudia Böckstiegel
Luzern
Chairperson of the board
Joint signing authority (any two to sign)
Florian Regli
Wettingen
Member of the board
Joint signing authority (any two to sign)
Azad Bonni
Basel
Member of the board
Joint signing authority (any two to sign)
Building smart people network graph...
Fetching people and their companies
Address & Locations
Primary Address
Loading map...
| No. | Journal No. | Journal date | SOGC | SOGC date | Page / ID |
|---|---|---|---|---|---|
| 1 | 40767 | 10.09.2025 | 177 | 15.09.2025 | 1006432616 |
| 2 | 37382 | 20.08.2025 | 162 | 25.08.2025 | 1006415524 |
| 3 | 18900 | 28.04.2025 | 83 | 01.05.2025 | 1006320984 |
| 4 | 6937 | 12.02.2025 | 32 | 17.02.2025 | 1006258231 |
| 5 | 39395 | 09.09.2024 | 177 | 12.09.2024 | 1006127745 |
| 6 | 28862 | 02.07.2024 | 129 | 05.07.2024 | 1006076570 |
| 7 | 17287 | 22.04.2024 | 80 | 25.04.2024 | 1006017361 |
| 8 | R4638 | 30.01.2024 | R23 | 02.02.2024 | 1005950763 |
| 9 | 3328 | 22.01.2024 | 17 | 25.01.2024 | 1005943534 |
| 10 | 46238 | 10.11.2023 | 222 | 15.11.2023 | 1005885029 |
Company Purpose
Wissenschaftliche Forschung im Bereich der Krebstherapie und Immunologie; Herstellung, Vermarktung und Verwertung pharmazeutischer Produkte; Erwerb, Verwaltung und Veräusserung von anderen Unternehmungen, Beteiligungen und anderen Vermögenswerten; kann Liegenschaften erwerben, verwalten und veräussern.